Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • DAL vs MRNA✓SelectedUSD · MRNADAL vs MRNA performance historyLatest closeAs of+0.69%11/18
Stock and ETF performance explorer

DAL vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+119.8%
MRNA return
-20.0%
Excess return
+139.8%
Maximum drawdown
-47.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+0.7%-4.8%+5.5%+1.0%
7D-7.1%-20.9%+13.8%-5.8%
30D+13.7%-13.3%+27.0%+14.5%
3M-0.7%+212.6%-213.2%-10.9%
6M+21.5%+309.0%-287.6%+3.4%
YTD+23.6%+567.3%-543.7%-4.1%
1Y+50.2%+689.7%-639.5%+12.9%
3Y+143.4%+157.4%-14.1%+104.5%
5Y+119.8%-21.7%+141.5%+79.6%
All+119.8%-20.0%+139.8%+79.6%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling